The inactive ingredients in Wegovy — and why most concerns about them are misplaced

Wegovy's excipients include disodium phosphate dihydrate, sodium chloride, polysorbate 80, hydrochloric acid and sodium hydroxide in water for injection.
Polysorbate 80 is the excipient most likely to matter clinically, people with a known allergy to it or to polyethylene glycol (PEG) should discuss this before starting.
The inactive ingredients are consistent across all Wegovy dose strengths (0.25 mg through to 2.4 mg and the newer 7.2 mg pen).
None of the excipients contain gluten, latex or significant sodium at clinical doses, a fact that reassures many patients with specific dietary or skin concerns.

Wegovy's inactive ingredients are the excipients that give the injection its stability and tolerability — not active medicines themselves. The formulation contains disodium phosphate dihydrate, sodium chloride, polysorbate 80, hydrochloric acid and sodium hydroxide, all dissolved in water for injection. These are standard pharmaceutical excipients found in countless injectable medicines, chosen specifically to keep semaglutide stable and the injection comfortable. That said, a small number of people do have sensitivities worth knowing about (particularly to polysorbate 80) and this is something any prescriber will ask about as part of a clinical assessment before treatment begins. Wegovy is a prescription-only medicine, which means it can only be dispensed following that kind of individual review.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What each ingredient actually does, and who needs to take note

The misconception worth clearing up first: excipients are not fillers or adulterants

A question that comes up regularly (understandably so) is whether the non-active contents of a medicine somehow dilute or interfere with it. The short answer is no. Pharmaceutical excipients exist to make the active ingredient work safely in the body: they maintain the right pH, prevent the medicine degrading before it is used, and help the liquid behave consistently through the pen mechanism. Without them, semaglutide in solution would be chemically unstable and potentially irritating to inject. Thinking of excipients as mere padding is the misconception this page can gently set aside.

Wegovy's formulation has been through the same regulatory scrutiny as its active ingredient. The NHS semaglutide medicines page lists the full excipient profile alongside the prescribing information, and the Wegovy SmPC on the electronic Medicines Compendium gives the exact concentrations for anyone who needs that level of detail. Our clinical team reviews each person's medical history before prescribing, including any known medication sensitivities.

What each excipient is there for

Disodium phosphate dihydrate and sodium chloride together act as a buffer and tonicity agent, keeping the solution at a pH and salt concentration close to that of body fluids. This is why the injection is generally well tolerated at the site rather than causing the sharp sting associated with solutions at the wrong pH. Hydrochloric acid and sodium hydroxide are added in trace amounts during manufacture solely to fine-tune that pH to the correct range; they are not present as medicines or preservatives in any meaningful sense.

Polysorbate 80 is a surfactant, it prevents semaglutide molecules from clumping together or sticking to the inner surface of the pen cartridge. It is widely used in vaccines and injectable medicines. The reason it warrants specific attention is that people with a documented allergy to polyethylene glycol or polysorbate compounds can, in rare cases, experience hypersensitivity reactions. If you have previously reacted to either, that is exactly the kind of history a prescriber needs to know before treatment starts. You can read more about semaglutide's active mechanism alongside this excipient context if you want the full picture.

Water for injection is the solvent that carries everything else. It is highly purified, endotoxin-controlled water (not tap or distilled water) prepared to strict pharmaceutical standards.

Sodium content and dietary sensitivities

Some people on low-sodium diets or with kidney conditions ask whether Wegovy's sodium chloride content is clinically significant. At the concentrations used in a single weekly dose, the contribution to overall daily sodium intake is negligible, far below the threshold that would need to be counted for a restricted diet. The formulation is also latex-free, and nothing in the excipient list is derived from gluten-containing grains. For people managing coeliac disease alongside a weight management plan, this is one less thing to worry about.

The comparison between Ozempic and Wegovy's ingredients is a related question, both contain semaglutide but the products are formulated and licensed differently, and that distinction matters. If you are also curious about how the oral tablet compares, the full Wegovy ingredients overview covers the injection and tablet formulations side by side.

What this means in practice before starting treatment

For the vast majority of people, the inactive ingredients in Wegovy require no special consideration beyond what a routine consultation already covers. The polysorbate 80 point is the one exception, if there is any history of reactions to PEG-containing products, that conversation should happen with a prescriber before the first pen is used, not after.

It is also worth noting that the excipient profile is identical across all dose strengths, so switching from the 0.25 mg starting dose up through the titration schedule does not change the tolerability picture for those components. If you would like a broader breakdown of wegovy ingredientes, including how each component is listed across different markets, that page sets out the full picture clearly. For context on how Wegovy is priced as a private prescription, the weight loss treatment overview sets out what is typically included in private treatment costs in the UK.

If you are considering Wegovy and want to understand what the main ingredient in Wegovy actually does before a prescriber reviews your full history, including any known ingredient sensitivities, check your eligibility with our clinical team. It is a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions